1. Home
  2. CYTH vs KNW Comparison

CYTH vs KNW Comparison

Compare CYTH & KNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • KNW
  • Stock Information
  • Founded
  • CYTH 1990
  • KNW 1998
  • Country
  • CYTH United States
  • KNW United States
  • Employees
  • CYTH N/A
  • KNW N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • KNW Industrial Machinery/Components
  • Sector
  • CYTH Health Care
  • KNW Industrials
  • Exchange
  • CYTH Nasdaq
  • KNW Nasdaq
  • Market Cap
  • CYTH 35.5M
  • KNW 33.3M
  • IPO Year
  • CYTH N/A
  • KNW N/A
  • Fundamental
  • Price
  • CYTH $1.26
  • KNW $0.43
  • Analyst Decision
  • CYTH Strong Buy
  • KNW Buy
  • Analyst Count
  • CYTH 3
  • KNW 1
  • Target Price
  • CYTH $3.20
  • KNW $1.00
  • AVG Volume (30 Days)
  • CYTH 25.8K
  • KNW 351.3K
  • Earning Date
  • CYTH 08-12-2024
  • KNW 08-12-2024
  • Dividend Yield
  • CYTH N/A
  • KNW N/A
  • EPS Growth
  • CYTH N/A
  • KNW N/A
  • EPS
  • CYTH N/A
  • KNW N/A
  • Revenue
  • CYTH $1,126,444.00
  • KNW N/A
  • Revenue This Year
  • CYTH $28.30
  • KNW N/A
  • Revenue Next Year
  • CYTH $14.19
  • KNW N/A
  • P/E Ratio
  • CYTH N/A
  • KNW N/A
  • Revenue Growth
  • CYTH N/A
  • KNW N/A
  • 52 Week Low
  • CYTH $0.89
  • KNW $0.23
  • 52 Week High
  • CYTH $2.12
  • KNW $0.99
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 48.10
  • KNW 40.61
  • Support Level
  • CYTH $1.13
  • KNW $0.43
  • Resistance Level
  • CYTH $1.40
  • KNW $0.52
  • Average True Range (ATR)
  • CYTH 0.09
  • KNW 0.07
  • MACD
  • CYTH 0.02
  • KNW -0.00
  • Stochastic Oscillator
  • CYTH 48.15
  • KNW 28.83

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About KNW Know Labs Inc.

Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.

Share on Social Networks: